Panagene Inc
KOSDAQ:046210
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 547
3 145
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Panagene Inc
Cash from Operating Activities
Panagene Inc
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
Panagene Inc
KOSDAQ:046210
|
Cash from Operating Activities
â‚©649.9m
|
CAGR 3-Years
-43%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Cash from Operating Activities
â‚©812.1B
|
CAGR 3-Years
42%
|
CAGR 5-Years
22%
|
CAGR 10-Years
34%
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Cash from Operating Activities
-â‚©29.1B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
P
|
PharmaResearch Co Ltd
KOSDAQ:214450
|
Cash from Operating Activities
â‚©149.5B
|
CAGR 3-Years
32%
|
CAGR 5-Years
45%
|
CAGR 10-Years
25%
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Cash from Operating Activities
â‚©86.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
74%
|
CAGR 10-Years
43%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Cash from Operating Activities
-â‚©23.6B
|
CAGR 3-Years
18%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
Panagene Inc
Glance View
PANAGENE Inc. engages in the molecular diagnostics business. The company is headquartered in Daejeon, Daejeon and currently employs 71 full-time employees. The company went IPO on 2000-08-16. The firm develops selective deoxyribonucleic acid (DNA) amplification technology and detection technology which used in the drug susceptibity testing, single nucleotide sequence variation inspection, infectious diseases hospital inspection and other DNA relates diseases inspection. The Company’s customs mainly include DAKO, AdvanDx, Abbott, LSI Medience Corporation and others.
See Also
What is Panagene Inc's Cash from Operating Activities?
Cash from Operating Activities
649.9m
KRW
Based on the financial report for Jun 30, 2025, Panagene Inc's Cash from Operating Activities amounts to 649.9m KRW.
What is Panagene Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-28%
The average annual Cash from Operating Activities growth rates for Panagene Inc have been -43% over the past three years , -28% over the past five years .